![Use of the C4.5 machine learning algorithm to test a clinical](http://s1.studyres.com/store/data/001913350_1-baad60b7968abd57e65f221a19540237-300x300.png)
Use of the C4.5 machine learning algorithm to test a clinical
... Abstract. Well-designed medical decision support system (DSS) have been shown to improve health care quality. However, before they can be used in real clinical situations, these systems must be extensively tested, to ensure that they conform to the clinical guidelines (CG) on which they are based. E ...
... Abstract. Well-designed medical decision support system (DSS) have been shown to improve health care quality. However, before they can be used in real clinical situations, these systems must be extensively tested, to ensure that they conform to the clinical guidelines (CG) on which they are based. E ...
(PSD) November 2016 PBAC Meeting - (Word 135KB)
... some tumour types do not respond well to SSAs, and that pegvisomant is a good treatment option in these cases. The advice also stated that biochemical control with pegvisomant is greater when it is used in combination with long-acting SSAs and combination therapy allows for pegvisomant to be prescri ...
... some tumour types do not respond well to SSAs, and that pegvisomant is a good treatment option in these cases. The advice also stated that biochemical control with pegvisomant is greater when it is used in combination with long-acting SSAs and combination therapy allows for pegvisomant to be prescri ...
168767_DrMaddin - Skin Therapy Letter
... is relatively cheap, but must be applied on three successive nights to be effective. It is considered the safest treatment for pregnant women and very young children, although there are no studies to confirm the lack of toxicity. For many years lindane was the preferred therapy until concern was voic ...
... is relatively cheap, but must be applied on three successive nights to be effective. It is considered the safest treatment for pregnant women and very young children, although there are no studies to confirm the lack of toxicity. For many years lindane was the preferred therapy until concern was voic ...
Detailed Advice - Scottish Medicines Consortium
... Summary of evidence on comparative efficacy Azelaic acid is a dicarboxylic acid. The exact mechanism by which azelaic acid interferes with the pathogenic events in rosacea is unknown but it may exert an anti-inflammatory effect by inhibition of the generation and action of reactive oxygen species an ...
... Summary of evidence on comparative efficacy Azelaic acid is a dicarboxylic acid. The exact mechanism by which azelaic acid interferes with the pathogenic events in rosacea is unknown but it may exert an anti-inflammatory effect by inhibition of the generation and action of reactive oxygen species an ...
SP Koppikar Clinical Experiences of 70 Years in
... of a pessimist being "A man who wears a belt and braces", So, inspite of no attacks, I gave one dose of Tuberculin aviare 1000 and Psorinum 1000 each at intervals of 2 to 3 months. The cure was permanent. Well, I started getting quite a number of similar or rather same problems, many from the hospit ...
... of a pessimist being "A man who wears a belt and braces", So, inspite of no attacks, I gave one dose of Tuberculin aviare 1000 and Psorinum 1000 each at intervals of 2 to 3 months. The cure was permanent. Well, I started getting quite a number of similar or rather same problems, many from the hospit ...
Falling Short
... treatment. Without consistent access to the right medicines at the right time, TB patients can default on their treatment and continue infecting those around them. Worse, they risk the development of drug-resistant TB strains or even death. This report presents new evidence to document the challenge ...
... treatment. Without consistent access to the right medicines at the right time, TB patients can default on their treatment and continue infecting those around them. Worse, they risk the development of drug-resistant TB strains or even death. This report presents new evidence to document the challenge ...
Hepatitis C Treatment
... INDICATIONS: Depend upon the brand of Ribavirin used* Copegus is approved for use with pegintereferon alfa-2a for the treatment of chronic hepatitis C with compensated liver disease. Rebetrol tablet formulation is approved for use with peginterferon alfa-2a for the treatment of chronic hepatitis C ...
... INDICATIONS: Depend upon the brand of Ribavirin used* Copegus is approved for use with pegintereferon alfa-2a for the treatment of chronic hepatitis C with compensated liver disease. Rebetrol tablet formulation is approved for use with peginterferon alfa-2a for the treatment of chronic hepatitis C ...
Treatment Options for Clozapine-Induced Enuresis: A
... the various patients described in the case reports (range: 150-900 mg/day); however, no one exceed the maximum recommended dose of 900 mg/day and most were within the expected therapeutic range of 300-600 mg/day.1 The dose of the interventions used for treating the enuresis were within the ranges sp ...
... the various patients described in the case reports (range: 150-900 mg/day); however, no one exceed the maximum recommended dose of 900 mg/day and most were within the expected therapeutic range of 300-600 mg/day.1 The dose of the interventions used for treating the enuresis were within the ranges sp ...
Anthelminthic drugs
... Treatment of trematodal infections • Metrifonate – prodrug, activated non-enzymatically • the active metabolite is dichlorvinyl dimethylphosphate (dichlorvos, DDVP), a cholinesterase inhibitor • fast inactivated in the plasma • depolarizing muscle relaxant ...
... Treatment of trematodal infections • Metrifonate – prodrug, activated non-enzymatically • the active metabolite is dichlorvinyl dimethylphosphate (dichlorvos, DDVP), a cholinesterase inhibitor • fast inactivated in the plasma • depolarizing muscle relaxant ...
5 Things to Know About Prescriptions for Buprenorphine/Naloxone
... surrounding the stigma associated with methadone. Although increased access is important, there have been reports of errors during the dispensing process as a result of pharmacy teams not understanding the many unique elements in dispensing this drug. Although physicians are required to be knowledge ...
... surrounding the stigma associated with methadone. Although increased access is important, there have been reports of errors during the dispensing process as a result of pharmacy teams not understanding the many unique elements in dispensing this drug. Although physicians are required to be knowledge ...
European guideline for the management of scabies
... him/herself, the hands should not be washed after application. Attention should be given to application at the tips of the ® ngers and under the nails (especially in crusted scabies). If the lotion/cream is applied by someone without scabies, that person should wear (medical) disposable gloves. If t ...
... him/herself, the hands should not be washed after application. Attention should be given to application at the tips of the ® ngers and under the nails (especially in crusted scabies). If the lotion/cream is applied by someone without scabies, that person should wear (medical) disposable gloves. If t ...
19-60014-000-NeuroStar-TMS-Therapy-External-Review
... placebo-controlled and are not conducted as comparative trials. When comparing the results of TMS to antidepressant drug therapy, it is important to note that patients in the NeuroStar TMS registration trial had a treatment resistant form of depression, while in contrast, patients in the drug regis ...
... placebo-controlled and are not conducted as comparative trials. When comparing the results of TMS to antidepressant drug therapy, it is important to note that patients in the NeuroStar TMS registration trial had a treatment resistant form of depression, while in contrast, patients in the drug regis ...
Document
... The PCSS-M MENTORS are members of medical specialty societies and provide mentoring support and educational services based on evidence-based practice guidelines. The efforts of PCSS-M are coordinated by a STEERING COMMITTEE composed of representatives from the Federal government and the leading pain ...
... The PCSS-M MENTORS are members of medical specialty societies and provide mentoring support and educational services based on evidence-based practice guidelines. The efforts of PCSS-M are coordinated by a STEERING COMMITTEE composed of representatives from the Federal government and the leading pain ...
Balancing the outcomes: reporting adverse events
... that occur in groups of patients who would normally be excluded from trials (eg, because of illness severity, comorbid conditions or the need for potentially confounding therapies), these do not allow clinicians to quantify the risk of a treatment26 and can give markedly different impressions of the ...
... that occur in groups of patients who would normally be excluded from trials (eg, because of illness severity, comorbid conditions or the need for potentially confounding therapies), these do not allow clinicians to quantify the risk of a treatment26 and can give markedly different impressions of the ...
Clinical Trials and Safety Surveillance of Drugs in Development
... An adverse reaction, the nature or severity of which is not consistent with the applicable product information (e.g., Investigator’s Brochure for an unapproved investigational medicinal product). Until source documents are amended, expedited reporting is required for additional occurrences of the ...
... An adverse reaction, the nature or severity of which is not consistent with the applicable product information (e.g., Investigator’s Brochure for an unapproved investigational medicinal product). Until source documents are amended, expedited reporting is required for additional occurrences of the ...
Implementation of Bridging Study
... for waiving bridging studies with reference to DOH announcements of waiving clinical trials. If the drug falls within the category that “requires submission of information proving no existence of ethnic differences”, it should be evaluated following this flowchart after the one year phase-in period. ...
... for waiving bridging studies with reference to DOH announcements of waiving clinical trials. If the drug falls within the category that “requires submission of information proving no existence of ethnic differences”, it should be evaluated following this flowchart after the one year phase-in period. ...
Substitution treatment Methadone 2 stage Engl
... specific context of these treatments in Belgium. Simultaneously the research brought into light a number of important questions about the evaluation of treatments situated on the cross lines between the psychological, social and medical fields. ...
... specific context of these treatments in Belgium. Simultaneously the research brought into light a number of important questions about the evaluation of treatments situated on the cross lines between the psychological, social and medical fields. ...
Comment on: “Use of the Fluocinolone Acetonide Intravitreal Implant
... [2]. In the USA, Retisert is indicated for ‘‘…the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye’’ [3] and not for DMO. The indication for ILUVIEN in the USA is for ‘‘…or the treatment of diabetic macular edema in patients who have been previously treated with ...
... [2]. In the USA, Retisert is indicated for ‘‘…the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye’’ [3] and not for DMO. The indication for ILUVIEN in the USA is for ‘‘…or the treatment of diabetic macular edema in patients who have been previously treated with ...
Abnormal uterine bleeding - Canadian Family Physician
... see you for her annual periodic health examination. She reports that her periods are becoming more irregular and unpredictable. Previously her menstrual cycle was 30 days, but during the past 6 months it has been 24 to 40 days. Her menses have been heavy since her second pregnancy 21 years ago and a ...
... see you for her annual periodic health examination. She reports that her periods are becoming more irregular and unpredictable. Previously her menstrual cycle was 30 days, but during the past 6 months it has been 24 to 40 days. Her menses have been heavy since her second pregnancy 21 years ago and a ...
Guidelines on the management of latent
... Ibrahim Abubakar declared that his employer received grants from National Institute of Health (£2.7 million for PREDICT study: Prognostic Evaluation of IGRAs and Skin test in a cohort of 10,000 contacts and migrants) and UK Department of Health (£900 000 for a randomized controlled trial to assess i ...
... Ibrahim Abubakar declared that his employer received grants from National Institute of Health (£2.7 million for PREDICT study: Prognostic Evaluation of IGRAs and Skin test in a cohort of 10,000 contacts and migrants) and UK Department of Health (£900 000 for a randomized controlled trial to assess i ...
etanercept level elisa m1887
... frequently administered to patients who suffer from diseases where inflammation is an important cause of the clinical symptoms, such as rheumatoid arthritis. Inhibition of the inflammation can increase the quality of life of a patient. Studying Etanercept drug levels in relation to ...
... frequently administered to patients who suffer from diseases where inflammation is an important cause of the clinical symptoms, such as rheumatoid arthritis. Inhibition of the inflammation can increase the quality of life of a patient. Studying Etanercept drug levels in relation to ...
| Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios Giovanni Sotgiu
... reduce linezolid-related toxicity and further enhance the role of this drug in managing cases with resistance beyond XDR-TB. According to the available information, bedaquiline and delamanid seem to be effective and well tolerated, pending confirmation from existing trials [17–22]. They might favour ...
... reduce linezolid-related toxicity and further enhance the role of this drug in managing cases with resistance beyond XDR-TB. According to the available information, bedaquiline and delamanid seem to be effective and well tolerated, pending confirmation from existing trials [17–22]. They might favour ...
Word version - Health Sciences Authority
... employees, or designated external parties, all of whom are referred to as the “applicant representative”, to submit the application for product registration in Singapore. The NRIC/FIN of the applicant representative entered must be the same as that used to login to access the PRISM application. ...
... employees, or designated external parties, all of whom are referred to as the “applicant representative”, to submit the application for product registration in Singapore. The NRIC/FIN of the applicant representative entered must be the same as that used to login to access the PRISM application. ...
Zonisamide (Zonegran®) Clinicians initiating this medication should
... Dose escalation should be slower in patients with mild to moderate hepatic impairment or renal impairment. The cost of zonisamide is comparable to other medications that are also used as adjunctive therapies. Zonisamide should be initiated by neurology consultants only, although GPs will be expected ...
... Dose escalation should be slower in patients with mild to moderate hepatic impairment or renal impairment. The cost of zonisamide is comparable to other medications that are also used as adjunctive therapies. Zonisamide should be initiated by neurology consultants only, although GPs will be expected ...
Guidelines on Choice and Selection of Antipsychotics
... Schizophrenia in Adults recommends that an oral antipsychotic be offered to individuals with newly diagnosed schizophrenia in conjunction with psychological interventions. The aim of treatment is to improve social and cognitive functioning and patients will often require long term treatment with ant ...
... Schizophrenia in Adults recommends that an oral antipsychotic be offered to individuals with newly diagnosed schizophrenia in conjunction with psychological interventions. The aim of treatment is to improve social and cognitive functioning and patients will often require long term treatment with ant ...